C-MOPP: the forgotten regimen plus Rituximab for untreated and relapsed follicular lymphoma.

C-MOPP is a chemotherapy regimen for the treatment of Non-Hodgkin lymphoma (NHL). Because rituximab improves results in B-cell NHL, we added rituximab to C-MOPP, giving it the term C-MOPP-R. We retrospectively report the results of C-MOPP-R treatment for follicular lymphoma at Saint Louis University Cancer Center from 2000-2009.

Asthma care quality for children with minority-serving providers.

Objective: To compare asthma care quality for children with and without minority-serving providers.

Design: Cross-sectional telephone survey of parents, linked with a mailed survey of their children's providers.

Setting: A Medicaid-predominant health plan and multispecialty provider group in Massachusetts.

Asthma self-assessment in a Medicaid population.

Background: Self-assessment of symptoms by patients with chronic conditions is an important element of disease management. A recent study in a commercially-insured population found that patients who received automated telephone calls for asthma self-assessment felt they benefitted from the calls. Few studies have evaluated the effectiveness of disease self-assessment in Medicaid populations.

Outcomes after periodic use of inhaled corticosteroids in children.

Background: Many children with persistent asthma use inhaled corticosteroids on a periodic basis. Clinical trials in adults suggest that periodic use of inhaled corticosteroids may be effective for patients with mild persistent asthma. However, scant information exists on the clinical outcomes of children with asthma who are using inhaled corticosteroids on a periodic basis in real-world settings.